Research Article Details

Article ID: A13959
PMID: 29671945
Source: J Diabetes
Title: The rs4686434 variant in the fetuin B (FETUB) locus is associated with intrahepatic triglyceride content in obese Chinese adults.
Abstract: BACKGROUND: This study explored associations of genetic variants in the fetuin B (FETUB) locus with intrahepatic triglyceride (IHTG) content. METHODS: Four tagging single-nucleotide polymorphisms (SNPs) of the FETUB locus and patatin-like phospholipase domain containing 3 (PNPLA3) rs738409 and transmembrane 6 super family member 2 (TM6SF2) rs58542926 were genotyped in 418 obese Chinese adults in whom serum FETUB and IHTG were measured. RESULTS: Subjects carrying the minor G allele for FETUB rs4686434 (AG/GG) had lower serum FETUB levels (mean [&#177;SD] 3.89&#8201;&#177;&#8201;1.36 vs 4.22&#8201;&#177;&#8201;1.46&#8201;&#956;g/mL; P&#8201;=&#8201;0.021) and IHTG content (12.7&#8201;&#177;&#8201;9.4% vs 14.6&#8201;&#177;&#8201;9.8%; P&#8201;=&#8201;0.045) than their controls (AA), whereas IHTG content was higher in those carrying the minor G allele for PNPLA3 rs738409 (CG/GG) than in their controls (CC; 14.5&#8201;&#177;&#8201;10.1% vs 12.0&#8201;&#177;&#8201;8.6%; P&#8201;=&#8201;0.012). After adjusting for potential confounders, IHTG content was lower in carriers of the minor G allele for FETUB rs4686434 (AG/GG vs AA, &#946; -2.27&#8201;&#177;&#8201;0.91, P&#8201;=&#8201;0.012), but was higher in carriers of the minor G allele for PNPLA3 rs738409 (CG/GG vs CC, &#946; 2.65&#8201;&#177;&#8201;0.97, P&#8201;=&#8201;0.006). There was a significant joint effect between FETUB rs4686434 and PNPLA3 rs738409 on IHTG content, with increasing genetic risk score (counting the risk allele of A in rs4686434 and G in rs738409) being associated with higher IHTG content (&#946; 1.85&#8201;&#177;&#8201;0.48, P&#8201;<0.001). CONCLUSIONS: Carrying the minor G allele for FETUB rs4686434 was significantly associated with decreased IHTG content and may affect hepatic triglyceride accumulation in individuals at high risk of non-alcoholic fatty liver disease.
DOI: 10.1111/1753-0407.12774